206 related articles for article (PubMed ID: 10521430)
41. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
Piatelli MJ; Doughty C; Chiles TC
J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
[TBL] [Abstract][Full Text] [Related]
42. Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells.
Wooten MW; Seibenhener ML; Neidigh KB; Vandenplas ML
Mol Cell Biol; 2000 Jul; 20(13):4494-504. PubMed ID: 10848576
[TBL] [Abstract][Full Text] [Related]
43. The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3.
Agazie YM; Movilla N; Ischenko I; Hayman MJ
Oncogene; 2003 Oct; 22(44):6909-18. PubMed ID: 14534538
[TBL] [Abstract][Full Text] [Related]
44. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
[TBL] [Abstract][Full Text] [Related]
45. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
46. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.
Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593
[TBL] [Abstract][Full Text] [Related]
47. Dopamine D(4) and D(2L) Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor.
Oak JN; Lavine N; Van Tol HH
Mol Pharmacol; 2001 Jul; 60(1):92-103. PubMed ID: 11408604
[TBL] [Abstract][Full Text] [Related]
48. PI3K is required for insulin-stimulated but not EGF-stimulated ERK1/2 activation.
Liu L; Xie Y; Lou L
Eur J Cell Biol; 2006 May; 85(5):367-74. PubMed ID: 16406609
[TBL] [Abstract][Full Text] [Related]
49. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
50. Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization.
Zhuang ZY; Xu H; Clapham DE; Ji RR
J Neurosci; 2004 Sep; 24(38):8300-9. PubMed ID: 15385613
[TBL] [Abstract][Full Text] [Related]
51. Cbl, IRS-1, and IRS-2 mediate effects of rosiglitazone on PI3K, PKC-lambda, and glucose transport in 3T3/L1 adipocytes.
Standaert ML; Kanoh Y; Sajan MP; Bandyopadhyay G; Farese RV
Endocrinology; 2002 May; 143(5):1705-16. PubMed ID: 11956152
[TBL] [Abstract][Full Text] [Related]
52. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
53. Ceramide-dependent regulation of p42/p44 mitogen-activated protein kinase and c-Jun N-terminal-directed protein kinase in cultured airway smooth muscle cells.
Conway A; Pyne NJ; Pyne S
Cell Signal; 2000 Dec; 12(11-12):737-43. PubMed ID: 11152959
[TBL] [Abstract][Full Text] [Related]
54. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells.
Liao DF; Monia B; Dean N; Berk BC
J Biol Chem; 1997 Mar; 272(10):6146-50. PubMed ID: 9045626
[TBL] [Abstract][Full Text] [Related]
55. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
56. Defective activation of atypical protein kinase C zeta and lambda by insulin and phosphatidylinositol-3,4,5-(PO4)(3) in skeletal muscle of rats following high-fat feeding and streptozotocin-induced diabetes.
Kanoh Y; Sajan MP; Bandyopadhyay G; Miura A; Standaert ML; Farese RV
Endocrinology; 2003 Mar; 144(3):947-54. PubMed ID: 12586772
[TBL] [Abstract][Full Text] [Related]
57. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes.
Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM
Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227
[TBL] [Abstract][Full Text] [Related]
58. Phosphorylation of the Grb2- and phosphatidylinositol 3-kinase p85-binding p36/38 by Syk in Lck-negative T cells.
von Willebrand M; Williams S; Tailor P; Mustelin T
Cell Signal; 1998 Jun; 10(6):407-13. PubMed ID: 9720763
[TBL] [Abstract][Full Text] [Related]
59. Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase.
Holt KH; Kasson BG; Pessin JE
Mol Cell Biol; 1996 Feb; 16(2):577-83. PubMed ID: 8552085
[TBL] [Abstract][Full Text] [Related]
60. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function.
Kojima H; Shinagawa A; Shimizu S; Kanada H; Hibi M; Hirano T; Nagasawa T
Exp Hematol; 2001 May; 29(5):616-22. PubMed ID: 11376875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
